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Introduction
Recently, Juvenile Arthritis Disease Activity Score (JADAS)
was found to be a valid instrument for assessment of
disease activity. JADAS was developed with erythrocyte
sedimentation rate (ESR) because C-reactive protein
(CRP) values were not available in all databases used to
validate the tool. Nordal et al compared recently in a Nor-
dic population the JADAS based on CRP with JADAS
based on ESR and concluded that these instruments
correlated closely, indicating that both scores can be
recommended for assessing disease activity in JIA.
Objectives
Determine JADAS-CRP and compare its performance to
the JADAS-ESR and to test the agreement of both
scores on each disease activity category, in a Portuguese
population with JIA.
Methods
A National cohort of patients with JIA, registered in
Rheumatic Diseases Portuguese Register, was selected.
Patients were included in the study when all disease
activity measures were available for JADAS-ESR and
CRP calculation and one visit per patient was randomly
selected. JADAS-CRP was adapted by replacing ESR
with CRP as the inflammatory marker. CRP was trun-
cated to a 0-10 scale, similar to the truncated ESR used
in JADAS. JADAS 27-CRP was calculated similarly to
JADAS 27-ESR as the simple linear sum of its four com-
ponents. Pearson correlations and K statistics were used
in analyses.
Results
358 children included, 65.4% were female, mean disease
duration 11.75 ± 9.03 years. 37,5% were persistent
oligoarticular, 14,8% had extended oligoarticular, 14,2%
were polyarticular rheumatoid factor negative, 8,4%
polyarticular RF positive, 10,9% systemic, 9,8% enthesi-
tis-related arthritis, 3,1% psoriatic arthritis and in 1,4%
patients we could not have access to the subtype of JIA.
The correlation coefficient was 0,967, p < 0,0001),
though the correlation coefficient between CRP and ESR
was only 0,335 (p < 0,0001). When comparing the
JADAS-ESR and JADAS-CRP within each subtype of
JIA, the strong correlation was maintained (all values of
correlation > 0.9 and all p-values < 0.0001). The agree-
ment between JADAS-ESR and CRP across the 4 activity
states (inactive disease, minimal disease activity, parent’s
acceptable symptom state and active disease) assessed
by K statistics was very good, showing 91.1% of
the observations in agreement, K = 0.867 (95%CI
0.824-0.91).
Conclusion
In our study the JADAS27 based on CRP and ESR corre-
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